£2
No changevs Sept 2024Active12231755Private limited companyChester
THERAFX LTD
Significant control: David John Roberts (25–50%), David John Evans (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Therafx Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Therafx Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
THERAFX LTD is an active private limited company (company number 12231755) incorporated on 27 September 2019, registered in Chester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 September 2025, showing net assets of £2 and cash of £2. Net assets were unchanged on the prior period.
Peer position · net assets
By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- Dr David John Roberts
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr David John Evans
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 27 September 20197 yrs ago
- Next accounts due
- 30 June 2027in 249 days
- Confirmation statement due
- 11 October 2027in 352 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
£2
No changevs Sept 2024Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £2 | £2 | — | — | — | — | — |
| 30 September 2024 | £2 | £2 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2 at 30 September 2025
- Incorporated five or more years agoIncorporated 27 September 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 352 days
- Next accounts duein 249 days
- Accounts period endNet assets £2 · dormant accounts
- Accounts period endNet assets £2 · dormant accounts
- Incorporated
08
Similar companies in Liverpool
- MEDICAL INTELLIGENCE GROUP LTDWirral · inc. Apr 2020
- ENVIRO SPORE PROBIOTICS LTDWirral · inc. Jan 2019
- TARA BIOLOGICS LIMITEDLiverpool · inc. Jul 2020
- ALIEN ASSET MANAGEMENT LTDParkgate · inc. Dec 2020
- CRYONISS LTD.Deeside · inc. Mar 2018
- PELHAM CONSULTING SERVICES LIMITEDMaghull · inc. May 2021
All companies incorporated on 27 September 2019 · in Sept 2019.
09
Reminders for THERAFX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.